𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Expression of Angiopoietin-2 gene in non-small cell lung cancer

✍ Scribed by Xing Lihua; Zhang Zhenxiang; Xu Yongjian


Publisher
Springer-Verlag
Year
2003
Tongue
Chinese
Weight
346 KB
Volume
23
Category
Article
ISSN
0510-9752

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Herceptest: Her2 expression and gene amp
✍ G. Cox; M. Vyberg; B. Melgaard; J. Askaa; A. Oster; K.J. O'Byrne πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 French βš– 343 KB πŸ‘ 2 views

HER2 is an erbB/HER type 1 tyrosine kinase receptor that is frequently over-expressed in malignant epithelial tumours. Herceptin, a humanised mouse monoclonal antibody to HER2, is proven therapeutically in the management of metastatic breast cancer, significantly prolonging survival when combined wi

Identification of TDE2 gene and its expr
✍ Audrey Player; John Gillespie; Takeshi Fujii; Junya Fukuoka; Tatiana Dracheva; D πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 French βš– 336 KB πŸ‘ 2 views

## Abstract __TDE2__, a gene with sequence similarity to the mouse testicular tumor‐differentially‐expressed (__Tde1__/__MUSTETU__) gene, was identified by serial analysis of gene expression (SAGE) in nonsmall cell lung cancers (NSCLC). Here we characterized the __TDE2__ gene and determined its tra

Chromogranin A gene expression in non-sm
✍ Abbona, Giancarlo; Papotti, Mauro; Viberti, Laura; Macr??, Luigia; Stella, Anna; πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 288 KB πŸ‘ 2 views

Evidence for the existence of neuroendocrine (NE) differentiation in non-small cell lung carcinomas (NSCLCs) is at present based on histochemical, ultrastructural, and immunohistochemical data. The aim of this study was to investigate the extent of NE differentiation in NSCLCs as revealed by mRNA an

Increased expression of the LGALS3 (Gale
✍ Akinobu Yoshimura; Akihiko Gemma; Yoko Hosoya; Eriko Komaki; Yukio Hosomi; Tetsu πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 83 KB πŸ‘ 2 views

## Abstract Patients with lung cancer have a poor prognosis because of the high metastatic potential of the neoplasm. Therefore, identifying new molecular targets for anti‐metastatic therapy is very important. To identify novel key factors of tumor metastasis in lung cancer, we established the gene